http://www.vancouversun.com/technology/better+worse+Canada+hook+Frankenfish/4150
For better or worse, Canada on hook for 'Frankenfish'
By Steve Bartlett, St. John's Telegram January 22, 2011 •Story•Photos ( 1 )
In a place built on fish five centuries ago, this is a fish tale like no other.Photograph by: File, Postmedia NewsST. JOHN'S — In a place built on fish five centuries ago, this is a fish tale like no other.
Controversial salmon research pioneered on Canada's East Coast decades ago is in the final stage of the U.S. approval process.
The science sees genetically engineered fish that grow twice as fast as wild salmon.
If the U.S. Food and Drug Administration gives it the go-ahead, the salmon will be the first genetically modified animal species approved for sale to Americans — a move that could open the floodgates to other engineered animals.
"Pioneers? Yes, and we have the bruises and scars to show it," says Ron Stotish, president and CEO of AquaBounty Technologies, the Massachusetts company hoping for the green light.
"It's always difficult to be first. You're the lightning rod for everyone who opposes your technology."
The science stemmed from the work of Memorial University in Newfoundland-based researchers Garth Fletcher and Choy Hew, and Peter Davies of Queen's University in Kingston, Ont.
In the 1980s, the team began injecting genes into Atlantic salmon to see if they could produce a fish better able to survive the province's frigid winter waters.
They were unable to produce such a salmon. However, they were eventually successful in transferring the gene.
"It took a number of years to do it," Fletcher said.
Using what they had learned, the researchers injected the fish with a growth hormone gene to try to create a salmon that matured faster.
That was in 1989. A eureka moment soon followed.
"We saw the first fast-growing fish in the summer of '90," Fletcher recalls.
The scientists then worked with Memorial University and the University of Toronto to protect the discovery, with the final patent coming in 1996.
That's the same year they were approached at an academic conference by Elliot Entis, who wanted to license the research.
He had started A/F Protein, a biotech company pursuing a fish antifreeze protein it could sell.
The firm reorganized and spun off AquaBounty Farms in 2000. Four years later, the name changed to AquaBounty Technologies.
It became publicly traded in 2006.
Around that time, AquaBounty started trying to get the sale of super salmon approved.
A process to approve the fish for market didn't exist at the time, and the U.S. agency spent a few years creating a regulatory mechanism.
In September, the FDA declared AquaBounty's genetically engineered salmon safe to eat and said it posed no environmental threat.
The company's quest and the FDA's approval has been met with waves of controversy.
Some critics have dubbed it "Frankenfish."
They question the safety of eating genetically engineering salmon. One of the main consumption fears is that dangerous allergens could be present in the fish.
Others wonder what will happen if the fish escape and breed with wild salmon. Such concerns are unfounded, Stotish said, arguing it's actually safer than traditional aquaculture because the genetically engineered salmon are sterile.
The detractors are in high places, though.
On Tuesday, Alaskan Senator Mark Begich said he'll soon introduce legislation to prevent the FDA from rubber-stamping AquaBounty's salmon.
"Many call them 'Frankenfish' for good reasons: a monster that threatens our wild stocks and their habitat, our food safety and economic harm to Alaska wild-salmon fishermen," Begich was quoted as saying at a marine-science event in Anchorage.
Outside the safety and ecological concerns, there is also a movement in the U.S. to have AquaBounty's fish labelled as being genetically modified, if the FDA approves it.
A bill was introduced in California earlier this month to make such packaging mandatory.
Most of the debate is happening in the U.S., but there is opposition in Canada, too.
AquaBounty has a production facility in Prince Edward Island, and a group opposing it met with P.E.I. Premier Robert Ghiz this month.
"People all over the world are very concerned that Prince Edward Island will become the sole producer of the first genetically engineered (GE) animals, if in fact the United States does license it for the dinner plate," Leo Broderick of the Council of Canadians told The Charlottetown Guardian following the meeting with Ghiz.
"It's a black eye for the province. We do not need this distinction or designation as the home of the Frankensalmon."
Sharon Labchuk of Earth Action, a P.E.I.-based environmental group, told the paper their premier doesn't have an issue with genetically modified food.
"He has no problem with eating them himself. . . . Now that he's a father, I don't think his daughter should be eating (GMO foods or animals) either," Labchuk said.
"I don't think anybody should be eating these foods because they have not been proven safe."
AquaBounty's Stotish says people railing against his company's salmon are uninformed or simply doing so because they oppose the technology behind genetically modified foods.
Stotish points to the FDA declaration that the fish are fit to eat. He says he's eaten and enjoyed the product.
"It's indistinguishable from any high-quality Atlantic salmon," he says.
Amid all the debate, Time magazine named AquaBounty's faster-growing salmon as one of 2010's best inventions.
"On the one hand, you have people who don't like technology decrying the use of this technology, and on the other hand, you have an unsolicited endorsement from a major publication, saying this is certainly one of the most interesting stories and perhaps one of the best technologies of the year," Stotish says.
Keeping a close eye on all this from where the salmon discovery hatched two decades ago is Fletcher, now the director of Memorial University's Ocean Sciences Centre.
"I guess it's my baby," he says. "And, certainly, a huge chunk of the development was done at Memorial here. The fish they are growing today still carry at least one gene from the Newfoundland salmon."
The amount of reaction to the fact that it could be approved for market by the FDA raised Fletcher's eyebrows.
"One day alone, I think there were 150 publications on the subject. Hey, I don't get citations like that on my science stuff."
As for the concerns, he says there needs to be a cultural education on the food product and echoes the fact the fish are sterile.
Time's nod, 20 years after that first fish was developed, came as a surprise to Fletcher. It's recognition he welcomes, though.
"I'm not too concerned about me, personally, but I felt this was good, this was a first for Newfoundland, a first for Memorial University — at least in this technology — and we were the pioneers anyway."
Stotish wouldn't hazard a guess as to when the FDA's final decision might come down. He says he wishes he knew.
"What they tell people is they don't work on timelines: 'When we're ready to grant approval, if we're ready to grant approval, we will do so and we haven't decided yet.'"
If the salmon gets the fin's-up from the U.S. agency, Fletcher believes it'll be proof of something the Natural Sciences and Engineering Research Council has always preached — that basic research can be turned into a business.
The scientist said he doesn't think the FDA will block sale of the salmon because there's no scientific rationale for doing so.
Stotish and AquaBounty's investors hope Fletcher is right.
The U.S. market for salmon is massive, with the country importing as much as 300,000 tonnes per year.
Stotish has no idea how much of that market his company could capture, but says a small percentage would make them successful.
sbartlett@thetelegram.com
Twitter.com/bartlett_steve
© Copyright (c) The Daily Telegraph
Read more: http://www.vancouversun.com/technol...+Frankenfish/4150953/story.html#ixzz1BujQtkNe
For better or worse, Canada on hook for 'Frankenfish'
By Steve Bartlett, St. John's Telegram January 22, 2011 •Story•Photos ( 1 )
In a place built on fish five centuries ago, this is a fish tale like no other.Photograph by: File, Postmedia NewsST. JOHN'S — In a place built on fish five centuries ago, this is a fish tale like no other.
Controversial salmon research pioneered on Canada's East Coast decades ago is in the final stage of the U.S. approval process.
The science sees genetically engineered fish that grow twice as fast as wild salmon.
If the U.S. Food and Drug Administration gives it the go-ahead, the salmon will be the first genetically modified animal species approved for sale to Americans — a move that could open the floodgates to other engineered animals.
"Pioneers? Yes, and we have the bruises and scars to show it," says Ron Stotish, president and CEO of AquaBounty Technologies, the Massachusetts company hoping for the green light.
"It's always difficult to be first. You're the lightning rod for everyone who opposes your technology."
The science stemmed from the work of Memorial University in Newfoundland-based researchers Garth Fletcher and Choy Hew, and Peter Davies of Queen's University in Kingston, Ont.
In the 1980s, the team began injecting genes into Atlantic salmon to see if they could produce a fish better able to survive the province's frigid winter waters.
They were unable to produce such a salmon. However, they were eventually successful in transferring the gene.
"It took a number of years to do it," Fletcher said.
Using what they had learned, the researchers injected the fish with a growth hormone gene to try to create a salmon that matured faster.
That was in 1989. A eureka moment soon followed.
"We saw the first fast-growing fish in the summer of '90," Fletcher recalls.
The scientists then worked with Memorial University and the University of Toronto to protect the discovery, with the final patent coming in 1996.
That's the same year they were approached at an academic conference by Elliot Entis, who wanted to license the research.
He had started A/F Protein, a biotech company pursuing a fish antifreeze protein it could sell.
The firm reorganized and spun off AquaBounty Farms in 2000. Four years later, the name changed to AquaBounty Technologies.
It became publicly traded in 2006.
Around that time, AquaBounty started trying to get the sale of super salmon approved.
A process to approve the fish for market didn't exist at the time, and the U.S. agency spent a few years creating a regulatory mechanism.
In September, the FDA declared AquaBounty's genetically engineered salmon safe to eat and said it posed no environmental threat.
The company's quest and the FDA's approval has been met with waves of controversy.
Some critics have dubbed it "Frankenfish."
They question the safety of eating genetically engineering salmon. One of the main consumption fears is that dangerous allergens could be present in the fish.
Others wonder what will happen if the fish escape and breed with wild salmon. Such concerns are unfounded, Stotish said, arguing it's actually safer than traditional aquaculture because the genetically engineered salmon are sterile.
The detractors are in high places, though.
On Tuesday, Alaskan Senator Mark Begich said he'll soon introduce legislation to prevent the FDA from rubber-stamping AquaBounty's salmon.
"Many call them 'Frankenfish' for good reasons: a monster that threatens our wild stocks and their habitat, our food safety and economic harm to Alaska wild-salmon fishermen," Begich was quoted as saying at a marine-science event in Anchorage.
Outside the safety and ecological concerns, there is also a movement in the U.S. to have AquaBounty's fish labelled as being genetically modified, if the FDA approves it.
A bill was introduced in California earlier this month to make such packaging mandatory.
Most of the debate is happening in the U.S., but there is opposition in Canada, too.
AquaBounty has a production facility in Prince Edward Island, and a group opposing it met with P.E.I. Premier Robert Ghiz this month.
"People all over the world are very concerned that Prince Edward Island will become the sole producer of the first genetically engineered (GE) animals, if in fact the United States does license it for the dinner plate," Leo Broderick of the Council of Canadians told The Charlottetown Guardian following the meeting with Ghiz.
"It's a black eye for the province. We do not need this distinction or designation as the home of the Frankensalmon."
Sharon Labchuk of Earth Action, a P.E.I.-based environmental group, told the paper their premier doesn't have an issue with genetically modified food.
"He has no problem with eating them himself. . . . Now that he's a father, I don't think his daughter should be eating (GMO foods or animals) either," Labchuk said.
"I don't think anybody should be eating these foods because they have not been proven safe."
AquaBounty's Stotish says people railing against his company's salmon are uninformed or simply doing so because they oppose the technology behind genetically modified foods.
Stotish points to the FDA declaration that the fish are fit to eat. He says he's eaten and enjoyed the product.
"It's indistinguishable from any high-quality Atlantic salmon," he says.
Amid all the debate, Time magazine named AquaBounty's faster-growing salmon as one of 2010's best inventions.
"On the one hand, you have people who don't like technology decrying the use of this technology, and on the other hand, you have an unsolicited endorsement from a major publication, saying this is certainly one of the most interesting stories and perhaps one of the best technologies of the year," Stotish says.
Keeping a close eye on all this from where the salmon discovery hatched two decades ago is Fletcher, now the director of Memorial University's Ocean Sciences Centre.
"I guess it's my baby," he says. "And, certainly, a huge chunk of the development was done at Memorial here. The fish they are growing today still carry at least one gene from the Newfoundland salmon."
The amount of reaction to the fact that it could be approved for market by the FDA raised Fletcher's eyebrows.
"One day alone, I think there were 150 publications on the subject. Hey, I don't get citations like that on my science stuff."
As for the concerns, he says there needs to be a cultural education on the food product and echoes the fact the fish are sterile.
Time's nod, 20 years after that first fish was developed, came as a surprise to Fletcher. It's recognition he welcomes, though.
"I'm not too concerned about me, personally, but I felt this was good, this was a first for Newfoundland, a first for Memorial University — at least in this technology — and we were the pioneers anyway."
Stotish wouldn't hazard a guess as to when the FDA's final decision might come down. He says he wishes he knew.
"What they tell people is they don't work on timelines: 'When we're ready to grant approval, if we're ready to grant approval, we will do so and we haven't decided yet.'"
If the salmon gets the fin's-up from the U.S. agency, Fletcher believes it'll be proof of something the Natural Sciences and Engineering Research Council has always preached — that basic research can be turned into a business.
The scientist said he doesn't think the FDA will block sale of the salmon because there's no scientific rationale for doing so.
Stotish and AquaBounty's investors hope Fletcher is right.
The U.S. market for salmon is massive, with the country importing as much as 300,000 tonnes per year.
Stotish has no idea how much of that market his company could capture, but says a small percentage would make them successful.
sbartlett@thetelegram.com
Twitter.com/bartlett_steve
© Copyright (c) The Daily Telegraph
Read more: http://www.vancouversun.com/technol...+Frankenfish/4150953/story.html#ixzz1BujQtkNe